Just over a year after announcing it would use its meganuclease technology to deactivate glutamine synthetase in Lonza's CHO cell line, Cellectis bioresearch claims it has succeeded. Lonza said the achievement will enable it to make further improvements to its GS Gene Expression System and shorten development timelines.
Bioscience Technology
Monday 25 July 2011
Cellectis reaches Lonza milestone
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment